Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 1992; Volume 262,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 449;
  • You have access
    Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    C A Paronis and S G Holtzman
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 1-9;
  • You have access
    Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
    S P Welch and D L Stevens
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 10-18;
  • You have access
    Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
    C C Chao, S Hu, T W Molitor, Y Zhou, M P Murtaugh, M Tsang and P K Peterson
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 19-24;
  • You have access
    Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    B Frances, R Gout, B Monsarrat, J Cros and J M Zajac
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 25-31;
  • You have access
    Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
    W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
  • You have access
    Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
    J Lundström, J E Lindgren, S Ahlenius and V Hillegaart
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 41-47;
  • You have access
    Metabolic effects of ritodrine in the fetal lamb.
    M P van der Weyde, M R Wright, S M Taylor, J E Axelson and D W Rurak
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 48-59;
  • You have access
    Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    A A Seymour, M M Asaad, B E Abboa-Offei, P L Rovnyak, S Fennell and W L Rogers
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 60-70;
  • You have access
    Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.
    I Findlay
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 71-79;
  • You have access
    Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    R H Jackson, M M Morrissey, M A Sills and M F Jarvis
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 80-89;
  • You have access
    Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    B Costall, A M Domeney, A J Farre, M E Kelly, L Martinez and R J Naylor
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 90-98;
  • You have access
    Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.
    K S Lee
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 99-108;
  • You have access
    Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
    S Ito, G Koren and P A Harper
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 109-113;
  • You have access
    Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex.
    G Bonanno and M Raiteri
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 114-118;
  • You have access
    M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle.
    L B Fernandes, A D Fryer and C A Hirshman
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 119-126;
  • You have access
    Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment.
    Q Wang, M A Hollinger and S N Giri
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 127-132;
  • You have access
    In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    R S Chang, P K Siegl, B V Clineschmidt, N B Mantlo, P K Chakravarty, W J Greenlee, A A Patchett and V J Lotti
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 133-138;
  • You have access
    In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    P K Siegl, R S Chang, N B Mantlo, P K Chakravarty, D L Ondeyka, W J Greenlee, A A Patchett, C S Sweet and V J Lotti
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 139-144;
  • You have access
    Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
    J Nagakawa, I Hishinuma, K Miyamoto, K Hirota, S Abe, T Yamanaka, K Katayama and I Yamatsu
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 145-150;
  • You have access
    Aminoglycoside-mediated calciuresis.
    W C Elliott and D S Patchin
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 151-156;
  • You have access
    Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats.
    M M el-Mas and A A Abdel-Rahman
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 157-165;
  • You have access
    Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
    B C Abels, J T Callis, R A Branch and R Sabra
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 166-172;
  • You have access
    Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
    J Lai, L Nunan, S L Waite, S W Ma, J W Bloom, W R Roeske and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 173-180;
  • You have access
    Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
    A Lecci, S Giuliani, P Santicioli and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 181-189;
  • You have access
    Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
    T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, H I Mosberg and F Porreca
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 190-197;
  • You have access
    Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery.
    B A Prins, M A Weber and R E Purdy
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 198-203;
  • You have access
    Reduction in potency of selective gamma-aminobutyric acidA agonists and diazepam in CA1 region of in vitro hippocampal slices from chronic flurazepam-treated rats.
    X H Xie and E I Tietz
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 204-211;
  • You have access
    Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
    C N Gillis, X Chen and M M Merker
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 212-216;
  • You have access
    Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
    J D Port, C C Debellis, J Klein, G A Peeters, W H Barry and M R Bristow
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 217-224;
  • You have access
    Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
    E Y Wu, J W Langston and D A Di Monte
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 225-230;
  • You have access
    Effects of xylamine on vascular neuroeffector transmission.
    O A Nedergaard, A K Cho and L A Waggaman
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 231-237;
  • You have access
    Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    A K Okwu, M E Ullian and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 238-245;
  • You have access
    Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
    P M Ormond, M A Basinger, M M Jones and K R Hande
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 246-251;
  • You have access
    Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney.
    C T Stier, C P Quilley and J C McGiff
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 252-256;
  • You have access
    Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production.
    R A Rabin, A M Edelman and J A Wagner
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 257-262;
  • You have access
    Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside.
    M Hamaguchi, T Ishibashi and S Imai
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 263-270;
  • You have access
    Age-associated enhancement of diquat-induced lipid peroxidation and cytotoxicity in isolated rat hepatocytes.
    L E Rikans and Y Cai
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 271-278;
  • You have access
    Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
    K L Preston, J T Sullivan, E C Strain and G E Bigelow
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 279-291;
  • You have access
    Identification and characterization of delta opioid binding sites in the bovine pineal.
    V J Aloyo
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 292-297;
  • You have access
    Cytochrome P-450 mediates bioactivation of organic nitrates.
    H Schröder
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 298-302;
  • You have access
    Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
    M van den Buuse
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 303-311;
  • You have access
    Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
    N H Lee, J Hu and E E el-Fakahany
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 312-316;
  • You have access
    Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    C S Wong, Y F Su, W D Watkins and K J Chang
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 317-326;
  • You have access
    Selective effects of cocaine on regional cerebral blood flow in the rat.
    E A Stein and S A Fuller
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 327-334;
  • You have access
    Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
    S F De Boer, J L Katz and R J Valentino
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 335-342;
  • You have access
    A central nervous system action of nitric oxide in blood pressure regulation.
    H Togashi, I Sakuma, M Yoshioka, T Kobayashi, H Yasuda, A Kitabatake, H Saito, S S Gross and R Levi
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 343-347;
  • You have access
    Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
    B Levant and C B Nemeroff
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 348-355;
  • You have access
    Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine.
    H M Jacocks and B M Cox
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 356-364;
  • You have access
    Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    S C Roerig, S Lei, K Kitto, J K Hylden and G L Wilcox
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 365-374;
  • You have access
    Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
    E Patterson, B J Scherlag and R Lazzara
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 375-382;
  • You have access
    Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    D M Mottola, W K Brewster, L L Cook, D E Nichols and R B Mailman
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 383-393;
  • You have access
    Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
    Y Katz, R Weizman, A Weizman and M Gavish
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 394-397;
  • You have access
    FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
    H Morimoto, M Murai, Y Maeda, M Yamaoka, M Nishikawa, S Kiyotoh and T Fujii
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 398-402;
  • You have access
    Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
    M Murai, H Morimoto, Y Maeda, S Kiyotoh, M Nishikawa and T Fujii
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 403-408;
  • You have access
    Endothelin-1 stimulates contraction and ion transport in the rat colon: different mechanisms of action.
    C Moummi, Y Xie, J F Kachur and T S Gaginella
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 409-414;
  • You have access
    Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors.
    A Ableitner and R Schulz
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 415-423;
  • You have access
    Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
    B K Kishore, S Ibrahim, P Lambricht, G Laurent, P Maldague and P M Tulkens
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 424-432;
  • You have access
    P-450-dependent arachidonic acid metabolism in rabbit olfactory microsomes.
    R M Laethem, C L Laethem, X Ding and D R Koop
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 433-438;
  • You have access
    Pharmacokinetic and pharmacodynamic comparisons between human granulocyte colony-stimulating factor purified from human bladder carcinoma cell line 5637 culture medium and recombinant human granulocyte colony-stimulating factor produced in Escherichia coli.
    H Tanaka and T Kaneko
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 439-444;
  • You have access
    In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat.
    T Grady, A K Saluja, M L Steer, M M Lerch, I M Modlin and R E Powers
    Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 445-449;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 262, Issue 1
1 Jul 1992
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics